While the clinical diagnosis of FD is challenging, the biochemical basis for FD diagnosis can be made easily based on decreased leukocyte α-GAL A activity in males and for females that have a normal enzyme level, mutation analysis of the alpha-galactosidase gene (GLA) using the dried blood spot (DBS) testing [4,5]. This evidence concerns the gene GLA and Fabry disease.